Cipla’s Generic Albuterol Inhaler Wins FDA Approval

April 8, 2020, 5:48 PM UTC

The U.S. Food and Drug Administration approved the first generic of Proventil HFA Metered Dose Inhaler, 90 mcg/Inhalation, for the treatment or prevention of bronchospasm.

  • The FDA granted approval of this generic albuterol sulfate inhalation aerosol to Cipla

To contact the reporter on this story:
Hari Govind in San Francisco at hgovind@bloomberg.net

To contact the editor responsible for this story:
Chakradhar Adusumilli at cadusumilli@bloomberg.net

© 2020 Bloomberg L.P. All rights reserved. Used with permission.

Learn more about Bloomberg Law or Log In to keep reading:

See Breaking News in Context

Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.

Already a subscriber?

Log in to keep reading or access research tools and resources.